AXIM Biotechnologies, Inc.

OTCPK:AXIM Stock Report

Market Cap: US$2.8m

AXIM Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AXIM?
Owner TypeNumber of SharesOwnership Percentage
Public Companies22,669,1258.14%
Individual Insiders51,884,25618.6%
General Public203,876,02273.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.5%.


Top Shareholders

Top 8 shareholders own 26.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.02%
Catalina Valencia
25,117,590US$251.2k26.9%no data
8.14%
Medical Marijuana, Inc.
22,669,125US$226.7k0%no data
7.11%
Sergei Svarovsky
19,800,000US$198.0k0%no data
2.15%
John Huemoeller
6,000,000US$60.0k0%no data
0.12%
Timothy Scott
333,333US$3.3k-75%no data
0.12%
Robert Cunningham
333,333US$3.3k-75%no data
0.09%
Peter O’Rourke
250,000US$2.5k-80%no data
0.018%
Robert Malasek
50,000US$500.10%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.